| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 10.725 | 12.720 | 21.797 | 33.265 | 10.555 | 33.032 | 41.923 | 54.206 | 75.494 |
| Total Income - EUR | - | 10.725 | 12.720 | 21.797 | 33.265 | 10.555 | 33.032 | 41.923 | 54.206 | 75.494 |
| Total Expenses - EUR | - | 4.604 | 5.671 | 5.983 | 13.929 | 3.899 | 7.898 | 9.137 | 11.185 | 14.711 |
| Gross Profit/Loss - EUR | - | 6.121 | 7.049 | 15.814 | 19.335 | 6.656 | 25.134 | 32.786 | 43.021 | 60.783 |
| Net Profit/Loss - EUR | - | 5.907 | 6.922 | 15.596 | 19.002 | 6.557 | 24.810 | 32.375 | 42.544 | 58.790 |
| Employees | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Nutridiab N.n. Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 84 | 46 | 9 | 0 | 682 | 334 | 605 | 177 | 1.297 |
| Current Assets | - | 6.565 | 7.614 | 20.260 | 33.948 | 27.185 | 31.639 | 35.648 | 46.964 | 67.800 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 1.106 | 1.400 | 3.037 | 4.400 | 3.885 | 3.929 | 18.642 | 38.011 | 48.140 |
| Cash | - | 5.460 | 6.214 | 17.223 | 29.548 | 23.300 | 27.710 | 17.006 | 8.952 | 19.660 |
| Shareholders Funds | - | 5.951 | 7.037 | 19.538 | 32.894 | 26.527 | 31.271 | 33.326 | 44.434 | 61.764 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 699 | 623 | 731 | 1.054 | 1.341 | 702 | 2.928 | 2.707 | 7.333 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Nutridiab N.n. Srl